Fierce Pharma

JUNE 12, 2024

As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target | As some pharma giants pump the brakes on big M&A deals, Bristol Myers Squibb—hot off a series of rapid-fire acquisitions in 2023—says it still has dealmaking cash to deploy if the right target comes along.

Pharma 325

Pharma 325

MedCity News

JUNE 12, 2024

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems. The post Why Is Moon Surgical’s New Commercial Robot System Important?

FDA 111

FDA 111

Fierce Pharma

JUNE 12, 2024

After being called out on some intellectual property claims late last year, Teva has fallen victim to the Federal Trade Commission’s (FTC’s) ongoing crusade against questionable drug patents. | A federal judge in New Jersey ruled that five of Teva’s patents on the metered dose inhaler for its asthma med ProAir HFA are “improperly listed” in the FDA’s Orange Book.

FDA 297

FDA Pharmaceutical 297

MedCity News

JUNE 12, 2024

There is a shortage of GLP-1s in the U.S. But experts have differing opinions on whose responsibility it is to be rationing the drugs. The post Who Should Be Responsible for Rationing GLP-1s? appeared first on MedCity News.

112

112

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

JUNE 12, 2024

Junshi revealed that a phase 3 trial of Loqtorzi plus Avastin prolonged the survival of first-line patients with hepatocellular carcinoma.

Patients 269

Patients 269

MedCity News

JUNE 12, 2024

Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease. More details will be presented at a medical conference this week. The post Avidity Bio’s RNA Therapy Flashes Early Signs of Treating a Muscular Dystrophy’s Root Cause appeared first on MedCity News.

Medical 112

Medical Biopharma Pharma 112

MedCity News

JUNE 12, 2024

Lack of adequate translation and interpreting services isn’t just an inconvenience, it is dangerous and potentially life-threatening. The post Reimagining the Language and Translation Space for Patients appeared first on MedCity News.

Patients 110

Patients 110

European Pharmaceutical Review

JUNE 12, 2024

The Association of the British Pharmaceutical Industry (ABPI) has welcomed proposals from the Conservative and Unionist Party’s recently published Manifesto for the UK’s 2024 general election. We encourage other parties to come forward with equally specific proposals to boost the sector, so that the progress of recent years can be maintained” For example, this includes plans to accelerate NHS patient access to new medicines, which propose to “ remove bureaucratic obstacles to the use of

Government 98

Government Medicine Manufacturing Pharmaceutical 98

Pharmaceutical Technology

JUNE 12, 2024

Lord James O'Shaughnessy, the former health minister, outlines places where the UK is falling behind other countries with clinical research.

105

105

PharmaVoice

JUNE 12, 2024

Small biotechs are saving time and money leveraging AI to develop new drugs, but incomplete data and disease complexity remain hurdles for the space.

Pharma 95

Pharma 95

Advertisement

MedCity News

JUNE 12, 2024

Strengthening patient financial education with the help of digital payment tools could be key to consumer engagement and cash recovery. The post For Community Hospitals, Curing Payment Confusion Requires Patient Friendly Solutions appeared first on MedCity News.

Patients 89

Patients Education Medical 89

pharmaphorum

JUNE 12, 2024

Johnson & Johnson has slammed a decision by NICE not to carry out a new appraisal of its antidepressant Spravato, claiming it has “grave concern” about access to new mental health treatments through NHS England.

85

85

PharmaTimes

JUNE 12, 2024

Two support cells, microglia and astrocytes, were found to communicate with each other

114

114

PharmaTech

JUNE 12, 2024

At BIO 2024 in San Diego, John Dunlop, PhD, chief scientific officer at Aliada Therapeutics, sat down for an interview with Pharmaceutical Technology to discuss the firm’s MODEL platform and its potential impact on therapeutic delivery for brain-related conditions.

Pharmaceutical 69

Pharmaceutical 69

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

PharmaTimes

JUNE 12, 2024

The donation will help scientists and clinicians collaborate and make new advances in research

101

101

Pharmaceutical Technology

JUNE 12, 2024

GlobalData’s newest update notes the impact of the growing anti-obesity market, apersonalised medicines, real-world evidence, and cell and gene therapies.

Medicine 80

Medicine Marketing 80

Pharmaceutical Commerce

JUNE 12, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Healthcare Healthcare 105

Pharmaceutical Technology

JUNE 12, 2024

Siegfried has announced the signing of binding agreements with Curia Global to acquire an early-phase CDMO site in Grafton, Wisconsin, US.

81

81

Advertisement

Distribution

Scott’s Directories

JUNE 12, 2024

The dental sector is flourishing with new technologies, treatments, and practices emerging. Effective communication is essential for businesses that want to succeed in this dynamic environment. Reaching the right dentists with the right message at the right time can be the difference between forging a valuable partnership and missing out on a key opportunity.

Specialization 52

Specialization Marketing Medical 52

PharmaTech

JUNE 12, 2024

The PharmTech Group spoke with BIOVECTRA's director of Business Development, Nucleic Acid Modalities, Jessica Madigan, about the concept of flexibility in outsourcing and the 2024 BIO Convention.

52

52

Scott’s Directories

JUNE 12, 2024

In today’s fast-paced digital world, integrating Customer Relationship Management (CRM) systems with lead generation tools is a game-changer for businesses, especially in the healthcare industry. This integration is vital for streamlining the process of capturing, tracking, and nurturing leads, ensuring that no opportunity slips through the cracks.

CRM 52

CRM Leads Customer Relationship Management Healthcare 52

PharmExec

JUNE 12, 2024

Investigators followed a group of people born from 1990-1996 to assess whether the association between preterm birth and income differs according to family socioeconomic status at birth.

52

52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

JUNE 12, 2024

Written Medicine is a digital solution that provides bilingual dispensing labels, described in a presentation at the NHS ConfedExpo conference in Manchester.

Medicine 52

Medicine 52

PharmExec

JUNE 12, 2024

In this part of his Pharmaceutical Executive video interview, Brice Challamel, Vice President, AI Products & Platforms, Moderna, talks about how Moderna will leverage its collaboration with OpenAI to accelerate the development and launch of its upcoming mRNA medicines

Medicine 52

Medicine Pharmaceutical 52

Pharmaceutical Commerce

JUNE 12, 2024

A retrospective cohort study investigates the characteristics of female patients with localized breast cancer that are associated with this nonpersistence.

Patients 52

Patients 52

PharmExec

JUNE 12, 2024

Outlining four considerations for biopharma companies in ensuring that their approach to replacing and filling key leadership positions is more truly aligned with future goals in business delivery and risk management.

Biopharma 52

Biopharma Management 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Pharmaceutical Technology

JUNE 12, 2024

In 2023, MASLD replaced the umbrella term of nonalcoholic fatty liver disease (NAFLD) to avoid the potentially stigmatising language of the former name.

Patients 52

Patients 52

PharmaTech

JUNE 12, 2024

The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.

52

52

PharmaVoice

JUNE 12, 2024

Although the rebuff makes approval “a bit more challenging,” Lykos is moving forward with the psychedelic-based treatment for PTSD.

52

52

PharmaTech

JUNE 12, 2024

AST’s VP of Business Development, Josh Russell, discusses the company’s impact on the pharmaceutical industry using innovative fill/finish equipment.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety